These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 22883390)

  • 1. Antidiabetic medications in patients with type 2 diabetes mellitus and severe renal impairment: an update.
    Aperis G
    J Ren Care; 2012 Sep; 38(3):170-1. PubMed ID: 22883390
    [No Abstract]   [Full Text] [Related]  

  • 2. [New oral hypoglycemic drugs in diabetic kidney disease].
    Dylewska M; Graczyk M
    Wiad Lek; 2017; 70(6 pt 2):1193-1196. PubMed ID: 29533912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vildagliptin in renal impairment.
    Dongre N; Kothny W
    J Nephrol; 2014 Jun; 27(3):349. PubMed ID: 24800907
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antidiabetic agents and renal insufficiency].
    Robles NR; Blanco J
    Nefrologia; 2002; 22(4):325-8. PubMed ID: 12369123
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral hypoglycemics and diabetic nephropathy.
    Hadler NM
    Clin J Am Soc Nephrol; 2008 Jan; 3(1):159-62. PubMed ID: 18178782
    [No Abstract]   [Full Text] [Related]  

  • 6. The efficacy and safety of dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus patients with severe renal impairment: a meta-analysis.
    Chen M; Liu Y; Jin J; He Q
    Ren Fail; 2016; 38(4):581-7. PubMed ID: 26915531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological management of type 2 diabetes mellitus in patients with CKD.
    Hamilton CA
    J Ren Care; 2012 Feb; 38 Suppl 1():59-66. PubMed ID: 22348365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tackling type 2 diabetes-associated cardiovascular and renal comorbidities: a key challenge for drug development.
    Adeghate EA; Kalász H; Al Jaberi S; Adeghate J; Tekes K
    Expert Opin Investig Drugs; 2021 Feb; 30(2):85-93. PubMed ID: 33327794
    [No Abstract]   [Full Text] [Related]  

  • 9. [Metformin is also recommended in mild and moderate renal failure].
    Zechmann S
    Praxis (Bern 1994); 2015 Mar; 104(7):370-1. PubMed ID: 25804780
    [No Abstract]   [Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptor gamma agonists in renal disease.
    Iglesias P; Díez JJ
    Eur J Endocrinol; 2006 May; 154(5):613-21. PubMed ID: 16645006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical experience with Glurenorm in type 2 diabetics with renal insufficiency].
    Rybka J; Gregorová A; Zmydlená A
    Vnitr Lek; 1988 Aug; 34(8):786-92. PubMed ID: 3176368
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diagnosis, implication, prevention and treatment of microalbuminuria].
    Schmieder RE; Bramlage P
    Dtsch Med Wochenschr; 2012 Jul; 137(27):1409-16; quiz 1417-8. PubMed ID: 22736183
    [No Abstract]   [Full Text] [Related]  

  • 13. [How I treat ... with metformin a diabetic patient with moderate renal insufficiency].
    Scheen AJ
    Rev Med Liege; 2013 Apr; 68(4):190-5. PubMed ID: 23755710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Can glitazones provide protection of the kidneys?].
    Bonnet F
    Journ Annu Diabetol Hotel Dieu; 2007; ():77-84. PubMed ID: 18610759
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of insulin and oral hypoglycemic medications in patients with diabetes mellitus and advanced kidney disease.
    Snyder RW; Berns JS
    Semin Dial; 2004; 17(5):365-70. PubMed ID: 15461745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 2 diabetes mellitus and renal impairment in a large outpatient electronic medical records database: rates of diagnosis and antihyperglycemic medication dose adjustment.
    Meyers JL; Candrilli SD; Kovacs B
    Postgrad Med; 2011 May; 123(3):133-43. PubMed ID: 21566423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoglycemics for the treatment of type 2 diabetes in patients with chronic kidney disease: a focus on new agents.
    Fang V; Wazny LD; Raymond CB
    CANNT J; 2012; 22(1):30-6; quiz 37-8. PubMed ID: 22558681
    [No Abstract]   [Full Text] [Related]  

  • 18. Novel hypoglycaemic agents: considerations in patients with chronic kidney disease.
    Game F
    Nephron Clin Pract; 2014; 126(1):14-8. PubMed ID: 24434725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of diabetes mellitus with oral antidiabetic agents].
    Bruns W
    Z Arztl Fortbild (Jena); 1988; 82(17):805-9. PubMed ID: 3062917
    [No Abstract]   [Full Text] [Related]  

  • 20. Renal Effects of SGLT-2 Inhibitors and Other Anti-diabetic Drugs: Clinical Relevance and Potential Risks.
    Lioudaki E; Whyte M; Androulakis ES; Stylianou KG; Daphnis EK; Ganotakis ES
    Clin Pharmacol Ther; 2017 Sep; 102(3):470-480. PubMed ID: 28480956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.